National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 13753 [2025-05071]

Download as PDF Federal Register / Vol. 90, No. 57 / Wednesday, March 26, 2025 / Notices regarding this collection contact Gail Duncan at 410–786–7278.) William N. Parham, III, Director, Division of Information Collections and Regulatory Impacts, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2025–05089 Filed 3–25–25; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Charter Renewal for Advisory Council on Blood Stem Cell Transplantation Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act (FACA), the Department of Health and Human Services is hereby giving notice that the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) has been renewed. DATES: The effective date of the charter renewal is February 19, 2025. FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant, Designated Federal Officer Health Systems Bureau, HRSA, 5600 Fishers Lane, 08W–59, Rockville, Maryland, 20857; 301–443–8036; or sgrant@hrsa.gov. SUPPLEMENTARY INFORMATION: ACBSCT advises, assists, consult withs, and makes recommendations to the Secretary of Health and Human Services (Secretary) on matters related to the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory. ACBSCT may also provide advice to the Administrator of HRSA. According to Public Law 109–129, and as amended, and 42 U.S.C. 274k (section 379 of the Public Health Service Act), the principal purpose of these programs is to increase the number of transplants for recipients suitably matched to biologically unrelated donors of bone marrow and cord blood. According to Public Law 109–129, and as amended, ACBSCT shall, as requested by the Secretary, discuss and make recommendations regarding the C.W. Bill Young Cell Transplantation Program or the National Cord Blood Inventory. It shall provide a consolidated, comprehensive source of expert, unbiased analysis, and recommendations to the Secretary on the latest advances in the science of blood stem cell transplantation and donation. ACBSCT may also review the khammond on DSK9W7S144PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:57 Mar 25, 2025 Jkt 265001 13753 state of the science, using adult stem cells and birthing tissues to develop new types of therapies for patients, to consider the potential inclusion of such new types of therapies in the C.W. Bill Young Cell Transplantation Program. The charter renewal for ACBSCT was approved on February 19, 2025. The filing date is February 19, 2025. The renewal of the ACBSCT charter gives authorization for the council to operate until February 19, 2027. A copy of the ACBSCT charter is available on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/ advisory-council. A copy of the charter also can be obtained by accessing the FACA database that is maintained by the Committee Management Secretariat under the General Services Administration. The website address for the FACA database is: https:// www.facadatabase.gov/. Scientific Review Officer, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 6707 Democracy Boulevard, Room 7343, Bethesda, MD 20817, (301) 594–8898, barnardm@ extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Maria G. Button, Director, Executive Secretariat. National Institutes of Health [FR Doc. 2025–05112 Filed 3–25–25; 8:45 am] Dated: March 20, 2025. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2025–05071 Filed 3–25–25; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of General Medical Sciences; Notice of Meeting BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity Applications. Date: April 24, 2025. Time: 12 p.m. to 1 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Michele L. Barnard, Ph.D., PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory General Medical Sciences Council. The meeting will be held as a virtual meeting and open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should submit a request using the following link: https:// www.nigms.nih.gov/Pages/ ContactUs.aspx at least 5 days prior to the event. The open session will also be videocast, closed captioned, and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov). The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory General Medical Sciences Council. Date: May 22, 2025. Open: 9:30 a.m. to 12:45 p.m. Agenda: For the discussion of programs; opening remarks; report of the Director, NIGMS; and other business of the Council. Closed: 2:00 p.m. to 5:00 p.m. E:\FR\FM\26MRN1.SGM 26MRN1

Agencies

[Federal Register Volume 90, Number 57 (Wednesday, March 26, 2025)]
[Notices]
[Page 13753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05071]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity 
Applications.
    Date: April 24, 2025.
    Time: 12 p.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, National Institute of 
Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, National Institute of Diabetes and 
Digestive and Kidney Diseases, National Institutes of Health, 6707 
Democracy Boulevard, Room 7343, Bethesda, MD 20817, (301) 594-8898, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2025-05071 Filed 3-25-25; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.